Compare BHVN & VRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BHVN | VRE |
|---|---|---|
| Founded | 2013 | 1949 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.6B |
| IPO Year | 2022 | 1995 |
| Metric | BHVN | VRE |
|---|---|---|
| Price | $11.25 | $18.85 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 14 | 3 |
| Target Price | ★ $27.69 | $18.67 |
| AVG Volume (30 Days) | ★ 1.9M | 1.9M |
| Earning Date | 01-01-0001 | 05-28-2026 |
| Dividend Yield | N/A | ★ 1.70% |
| EPS Growth | N/A | ★ 420.00 |
| EPS | N/A | ★ 0.80 |
| Revenue | N/A | ★ $288,434,000.00 |
| Revenue This Year | N/A | $4.77 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $23.58 |
| Revenue Growth | N/A | ★ 6.40 |
| 52 Week Low | $7.48 | $13.69 |
| 52 Week High | $37.36 | $18.89 |
| Indicator | BHVN | VRE |
|---|---|---|
| Relative Strength Index (RSI) | 45.94 | 82.00 |
| Support Level | $10.75 | $14.29 |
| Resistance Level | $11.80 | N/A |
| Average True Range (ATR) | 0.63 | 0.32 |
| MACD | -0.05 | 0.25 |
| Stochastic Oscillator | 16.63 | 98.51 |
Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder, and others.
Veris Residential Inc is a fully-integrated, self-administered and self-managed real estate investment trust (REIT). The company owns and operates a real estate portfolio comprised predominantly of multifamily rental properties located mainly in the Northeast and Class A office properties. The company performs substantially all real estate management, leasing, acquisition and development on an in-house basis. The properties are in three states in the Northeast, plus the District of Columbia. The company operates in two industry segments multifamily real estate & services and commercial & other real estate. The majority of revenue is from Multifamily real estate services.